U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231861) titled 'Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers' on Nov. 14.
Brief Summary: To Evaluate the Safety and Pharmacokinetics of Pranlukast hydrate in Healthy Adults.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Bronchial Asthma
Perennial Allergic Rhinitis
Intervention:
DRUG: Test Drug
AJU-R713
DRUG: Reference Drug
R713R
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AJU Pharm Co., Ltd.
Disclaimer: Curated by HT Syndication....